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Although insulin is known to regulate glucose metabolism and closely associate with liver cancer, the molecular mechanisms still
remain to be elucidated. In this study, we attempt to understand themechanism of insulin in promotion of liver cancer metabolism.
We found that insulin increased pyruvate kinase M2 (PKM2) expression through reactive oxygen species (ROS) for regulating
glucose consumption and lactate production, key process of glycolysis in hepatocellular carcinoma HepG2 and Bel7402 cells.
Interestingly, insulin-induced ROS was found responsible for the suppression of miR-145 and miR-128, and forced expression of
either miR-145 or miR-128 was sufficient to abolish insulin-induced PKM2 expression. Furthermore, the knockdown of PKM2
expression also inhibited cancer cell growth and insulin-induced glucose consumption and lactate production, suggesting that
PKM2 is a functional downstream effecter of insulin. Taken together, this study would provide a new insight into the mechanism
of insulin-induced glycolysis.
1. Introduction
Insulin is known to play an important role in human glu-
cose metabolism [1]. Many human diseases cause glucose
metabolism disorders such as diabetes and cancer [2, 3].
However, the molecular mechanisms of insulin in regulat-
ing glucose metabolism of cancer remain to be elucidated.
Changes of rate-limiting glycolytic enzymes are observed
during cancer metabolism. Among these enzymes, pyruvate
kinase (PK) plays a crucial role in catalyzing the formation
of pyruvate and ATP from phosphoenolpyruvate and ADP
[4, 5].There are four isoforms of PK in mammals, PKL, PKR,
PKM1, and PKM2. PKL, PKR, and PKM1 are tissue-specific
isoenzymes, whereas PKM2 is considered an embryonic
and cancer cell-specific isoform [6]. Evidence supports that
the loss of the tissue-specific isoenzymes and subsequent
expression of PKM2 are involved in tumor initiation aswell as
malignant progression. Knockdown of PKM2 expression or
the replacement of PKM2with PKM1 has been demonstrated
to inhibit cancer metabolism and tumor growth [5, 7].
Transcription factors such asHIF-1𝛼 and other genes relevant
to tumorigenesis are potent PKM2 activators, while a number
of genes associated with cell proliferation, metabolism, and
tumor growth are downstream targets of PKM2 [8–10].
Lines of evidence in recent years have suggested a crucial
role of reactive oxygen species (ROS) in cancer cellular
functions [11]. High levels of endogenous ROS production are
associated with cancer development [12, 13]. ROS, especially
hydrogen peroxide (H
2
O
2
), are also induced by a variety of
external stimulators including growth factors such as insulin
[14]. However, the role of ROS production in cancer cells in
response to insulin-induced glucose metabolism remains to
be elucidated.
Recently, miRNAs are known to be involved in many
human diseases, such as diabetes and cancer [15, 16]. miRNAs
are small, noncoding RNAs that have been confirmed to be
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a new kind of gene expression regulators through negatively
regulating protein-coding genes. The causal roles of miRNAs
in cancer have been well documented and miRNA-based
anticancer therapies are in development [17, 18]. Several miR-
NAs with evident roles in cancer are reported to participate
in insulin and ROS signaling pathways. For example, Let-
7 family regulates multiple aspects glucose metabolism in
multiple organs [19]; miR-143 regulates glucose metabolism
of cancer cells by targeting hexokinase 2 isoform (HK2) [20];
miR-21 is an important target of ROS [21]. Despite these
studies, whether or not miRNAs take part in insulin-induced
PKM2 expression and the underlying mechanisms by which
PKM2 exerts effects in this pathology remain unclear.
In the present study, we plan to study whether (1) ROS
are involved in insulin-regulated glycolysis in hepatocellular
carcinoma cells; (2) insulin regulates PKM2 expression via
ROS production; (3) insulin upregulates PKM2 expression
in ROS dependent manner through miRNAs expression; and
(4) PKM2 is required for insulin-induced aerobic glycolysis.
These studies will determine the role of ROS/miRNAs/PKM2
in mediating insulin effects and are helpful to understand the
mechanism of insulin in regulating hepatocellular carcinoma
cell glycolysis.
2. Materials and Methods
2.1. Reagents and Cell Culture. HumanHepG2 hepatocellular
carcinoma cells were obtained from American Type Culture
Collection (Manassas, VA, USA). Human hepatocellular
carcinoma cell lines BeL7402 were obtained from the Cell
Bank of the Chinese Academy of Science (Shanghai, China).
Cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 5% FBS, penicillin (100U/mL),
and streptomycin (100 𝜇g/mL) at 37∘C in 5% CO
2
incubator.
Trypsin (0.25%)/EDTA solution was used to detach the cells
for subculturing the cells. Insulin was purchased from Sigma
(St. Louis, MO).
2.2. ROSMeasurement. HepG2 cells were seeded in a 12-well
plate at 8 × 104 cells/well and cultured at 37∘C for 24 h. The
cells were then incubated in serum-free medium for 24 h,
followed by the pretreatment with catalase (1500U/mL) for
1 h. CM-H2DCFDA (5 𝜇M) (Invitrogen, USA) was added
and incubated with the cells for 10min. Cells were then
stimulated with insulin (200 nM) for 10min. The cells were
washed twice with phosphate-buffered saline (PBS) and fixed
with 10% buffered formalin.The images were captured with a
fluorescence microscope.
2.3. Malondialdehyde (MDA) Analysis. MDA levels in the
cells were determined by the thiobarbituric acid (TBA)
methodusing an assay kit according tomanufactory guidance
(Beyotime Biotechnology, Shanghai, China). Briefly, protein
samples were incubated with TBA at 100∘C for 15min, fol-
lowed by a centrifugation at 1000×g for 10min. Supernatants
were transferred to a 96-well plate, and the absorbance was
measured at 532 nm. The MDA levels were analyzed and
normalized to each sample protein concentration.
2.4. Measurement of Glucose Consumption and Lactate Pro-
duction. A total of 5 × 104 cells per well were seeded in
24-well plates and treated as above. Cells were trypsinized
and counted, while the supernatants of cell culture medium
were collected. The media were assayed immediately for
glucose and lactate levels by using glucose assay kit and
lactate assay kit (Biovision, Mountain View, CA) according
to the manufacturer’s instruction. The glucose consumption
and lactate production were normalized to cell number.
The experiments were performed with three replicates and
repeated for three times.
2.5. Real-Time RT-PCR. Total RNAs from cells were isolated
using TRIzol (Invitrogen, USA) according to the manufac-
turer’s instruction. cDNA synthesis was performed with 1 𝜇g
total RNAs using PrimeScriptTM RT reagent kit (Takara,
China). Aliquots of these cDNAs were used for quantitative
real-time PCR using SYBR Premix DimerEraser (Takara,
China). Expression levels of miR-145 and miR-128 were nor-
malized toU6 levels, expression levels of PKM2were normal-
ized to GAPDH level for each sample, and fold changes were
calculated by relative quantification (2−ΔΔCt). Primers used
were listed in Supplementary Table 1 in SupplementaryMate-
rial available online at http://dx.doi.org/10.1155/2014/504953.
2.6. Western Blotting and Antibodies. Cells were harvested
and lysed in radioimmunoprecipitation assay (RIPA) buffer
supplementedwith proteinase inhibitors cocktail.Theprotein
extracts were separated by SDS-polyacrylamide gel elec-
trophoresis (SDS-PAGE), transferred to nitrocellulose mem-
branes, and incubated with antibodies against PKM2 (Signal-
way Biotechnology, Pearland, TX), HIF-1𝛼 (BD Biosciences,
Sparks, MD), p70S6K1 (Cell Signaling Technology, Danvers,
MA), andGAPDH (Sigma, St. Louis,MO).The protein bands
were detected by incubating with horseradish peroxidase-
(HRP-) conjugated antibodies and visualized using the Super
Signal West Pico Chemiluminescent Substrate Kits (Thermo
Scientific, Rockford, IL).
2.7. Transient Transfection. Double strands miR-145 and
miR-128 and scrambled control precursors were synthesized
by Gene-pharma (Shanghai, China). HepG2 and Bel7402
cells were transfected with miR-145, miR-128, or scramble
control precursor by Lipofectamine 2000 (Invitrogen, USA)
according to themanufacturer’s instruction.The sequences of
miRNA precursors were listed in Supplementary Table 2.
Small interfering RNA (siRNA) duplex oligonucleotides
targeting human PKM2 (siPKM2) or scrambled control
(siSCR) were purchased from GenePharma (Shanghai,
China). HepG2 and Bel7402 cells were transfected with
siPKM2 or siSCR using Lipofectamine RNAiMax (Invitro-
gen) in serum-free Opti-MEM according to the manufac-
turer’s instruction. The sequences of small interfering RNA
for PKM2 were listed in Supplementary Table 3.
2.8. Cell Proliferation Assay. HepG2 and Bel7402 cells were
transfected with siPKM2 or the scrambled control and
cultured at 37∘C for 24 h. The cells were then trypsinized,
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resuspended, and seeded in a 96-well plate at 3000 cells
per well. The cell proliferation was measured at 12 h, 24 h,
48 h, 72 h, and 96 h using a Cell Counting Kit-8 (CCK-8)
(Dojindo Laboratories, Kumamoto, Japan) according to the
manufacturer’s instruction. All experiments were performed
in triplicate and were repeated for three times.
2.9. Statistical Analysis. Numerical results were presented as
mean ± SD. Statistical analysis was performed based on a
Student’s 𝑡-test at the significance level of 𝑃 < 0.05 using
GraphPad Prisms Software.
3. Results
3.1. Evidence for the Involvement of ROS in Insulin-Regulated
Glycolysis in Hepatocellular Carcinoma Cells. Although
insulin has been associated with a variety of cancers and liver
cell functions [22, 23], and ROS as secondary messengers
mediate the cancers signals, it remains unknown whether
ROS participate in transmitting insulin signaling. To this end,
ROS levels in response to insulin treatment were analyzed in
HepG2 cells. The cells were cultured in serum-free medium,
followed by the treatment of insulin. As shown in Figures 1(a)
and 1(b), treatment of cells with insulin led to higher ROS
levels. Addition of ROS scavenger catalase blocked the effect
of insulin treatment. Further experiments were performed
in HepG2 and Bel7402 cells using MDA analysis, a stable
indicator of oxidative stress. The results showed that MDA
levels in the insulin treatment were increased approximately
2-fold when compared with that in the cells without insulin
treatment. Catalase administration significantly decreased
insulin-induced MDA level (Figure 1(c)). These data suggest
that insulin is able to induce ROS production.
Next, we examined the effect of ROS on insulin-
regulating glucose energy metabolism. Insulin dramatically
increased glucose consumption and lactate production in
HepG2 and Bel7402 cells. Administration of catalase atten-
uated the increase in glucose metabolism induced by insulin
(Figures 1(d) and 1(e)). Thus, it appears that ROS participate
in insulin-regulated glycolysis.
3.2. Insulin Induced PKM2 Expression through ROS Produc-
tion. Pyruvate kinase M2 (PKM2), the key kinase, catalyzes
the last reaction of glycolysis and converts phosphoenolpyru-
vate (PEP) to pyruvate producing ATP. The expression
levels of PKM2 are used as one of the important metabolic
signatures of tumor cells. To test whether insulin promotes
glycolysis through regulating PKM2 expression, HepG2 cells
and Bel7402 cells were cultured in serum-free medium for
24 h and exposed to 200 nM of insulin for 0 h, 3 h, 6 h,
and 12 h. The immunoblotting results showed that insulin
significantly induced PKM2 expression in a time-dependent
manner (Figures 2(a) and 2(b)).
Since we showed that ROS were induced by insulin, we
tested whether insulin induced PKM2 expression through
ROS production. Pretreatment of HepG2 and Bel7402 cells
with catalase greatly suppressed the PKM2 protein levels
induced by insulin (Figures 2(c) and 2(d)). Further exper-
iments were performed by using real-time PCR to analyze
PKM2 mRNA expression levels. Similarly, PKM2 mRNA
levels were enhanced in response to insulin treatment and
decreased by catalase treatment (Figure 2(e)). This result
suggests that insulin-induced PKM2 expression requires ROS
production.
3.3. Insulin Upregulates PKM2 Expression in ROS Dependent
Manner through miR-145 and miR-128 Expression. There is
accumulating evidence for the miRNAs expression which
may be altered in response to exogenous agents that, at least in
part, induce intracellular insulin and oxidative stress [21, 24].
Hydrogen peroxide treatment suppressed miR-145 and miR-
128 expression (Figure S1), suggesting that ROS inhibit miR-
145 and miR-128 expression. To test whether insulin affect
miR-145 and miR-128 expression through ROS, we showed
that pretreatment of HepG2 and Bel7402 cells with catalase
greatly induced the expression levels of miR-145 and miR-
128 suppressed by insulin (Figure 3(a)). This result suggests
that insulin-regulated expression of miR-145 and miR-128
requires ROS production.
Our previous studies demonstrated that p70S6K1 is a
direct target of miR-145 and miR-128 in ovarian cancer cells
and glioma cells [25, 26]. We detected p70S6K1 and HIF-1𝛼
levels in response to insulin treatment. As shown in Figures
3(b), 3(c), and 3(d), p70S6K1 and HIF-1𝛼 protein levels were
increased after insulin treatment, and addition of miR-128
or miR-145 precursors inhibited insulin-induced p70S6K1
and HIF-1𝛼 expression. This result indicates that miR-128
or miR-145 is required for insulin-induced expression of
p70S6K1 and HIF-1𝛼. Since we showed that miR-128 and
miR-145 are required for insulin-induced p70S6K1 and HIF-
1𝛼 expression, we tested whether insulin-suppressing miR-
128 and miR-145 could play a role in PKM2 expression in
HepG2 andBel7402 cells. To test this, the cells were pretreated
with miR-128 and miR-145 and then stimulated with insulin.
miR-128 and miR-145 treatment inhibited insulin-induced
expression of PKM2 (Figures 3(b) and 3(e)), indicated that
miR-128 andmiR-145 are required for insulin-induced PKM2
expression.
3.4. PKM2 Is Critical for Insulin-Induced Aerobic Glycolysis
and Cell Growth. To test whether the inhibition of PKM2
expression attenuates insulin-induced glycolysis, HepG2 and
Bel7402 cells were transfected with siRNA against PKM2 or
scrambled control siRNA. After transfection with siPKM2,
the expression levels of PKM2 were markedly inhibited
by 70–80% when compared to scrambled control (Figures
4(a) and 4(b)). Insulin increased glucose consumption and
lactate production by 2-fold when compared to control group
without insulin treatment, while PKM2knockdown inhibited
insulin-induced glucose consumption and lactate production
to 50% and 60%, respectively (Figures 4(c) and 4(d)). These
results confirm that PKM2 is an important regulator in
insulin-regulating glycolysis.
Given that the energy metabolism is critical to the
survival and proliferation of cancer cells, we examined the
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Figure 1: Insulin promotedMDA production, glucose consumption and lactate production through ROS production in hepatocellular carcinoma cells. (a) HepG2
cells were seeded in a 12-well plate at 8 × 104 cells/well and cultured at 37∘C for 24 h. The cells were then incubated in serum-free medium for 24 h, followed by
the pretreatment with catalase (1500U/mL) for 1 h. CM-H2DCFDA (5𝜇M) was added and incubated with the cells for 10min. Cells were then stimulated with
insulin (200 nM) for 10min. The cells were washed thrice with 1x PBS. The representative images were captured with a fluorescence microscope. Bar, 50𝜇m. (b)
Levels of ROS fluorescence signals were quantified by ImageJ; ∗∗𝑃 < 0.01 compared with that of the same cell line treated without insulin and catalase; ##𝑃 < 0.01
compared to the cells treated with insulin alone. (c) HepG2 and Bel7402 cells were cultured in serum-free medium overnight. Then, the cells were treated with
catalase (1500U/mL) for 1 h, followed by insulin treatment (200 nM) for 12 h. The proteins were collected and subjected to MDA analysis. Data were presented by
mean± SD (𝑛 = 3). ∗∗ Significant difference compared with that of the same cell line treated or without insulin and catalase (𝑃 < 0.01); # and ## significant difference
compared to the cells treated with insulin alone (𝑃 < 0.05 and 𝑃 < 0.01, resp.). (d) and (e) HepG2 cells and Bel7402 cells were seeded in 24-well plates and cultured
in serum-free medium for 24 h, followed by the treatment with catalase (1500U/mL) for 1 h. Cells were then stimulated with insulin (200 nM) for 12 h.Themedium
was collected, and the glucose consumption and lactate production levels were analyzed. Data were mean ± SD from three independent experiments. ∗∗𝑃< 0.01
and ∗𝑃<0.05 compared with that of the same cell line treated without insulin and catalase;#𝑃<0.05 and ##𝑃<0.01 compared to the cells treated with insulin alone.
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Figure 2: Insulin-induced PKM2 expression was inhibited by catalase. (a) HepG2 cells and Bel7402 cells were cultured to 70% confluence
and then starved in serum-free medium for 24 h. The cells were exposed to 200 nM of insulin for 0 h, 3 h, 6 h, and 12 h. PKM2 levels were
determined by immunoblotting. (b) Relative densities of PKM2/GAPDH from three independent experiments were normalized to those
of control and presented as mean ± SD. ∗ Significant difference compared to control without insulin treatment (𝑃 < 0.05). (c) The starved
HepG2 cells and Bel7402 cells were pretreated with catalase (1500U/mL) for 1 h, followed by stimulationwith insulin (200 nM) for 6 h. Protein
expression was determined by immunoblotting. (d) Results were expressed as a percentage of the control cultures and were the mean ± SD
from three replications. (e) HepG2 cells and Bel7402 cells were treated as in (c). Total RNAs were extracted and used for real-time RT-PCR for
detecting PKM2 and GAPDHmRNA levels. ∗∗ Significant difference compared to the control without insulin and catalase treatment treated
without insulin and catalase treatment (𝑃 < 0.01); ## significant difference compared to the cells treated with insulin alone (𝑃 < 0.01).
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Figure 3: Continued.
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Figure 3: miR-145 and miR-128 are suppressed by insulin and involved in insulin-induced PKM2 expression. (a) HepG2 cells and Bel7402
cells were cultured overnight and switched to serum-free medium for 20 h. The starved cells were pretreated with catalase (1500U/mL) for
1 h. Insulin (200 nM) was added and the cells were incubated for 6 h. Total RNAs were extracted and used for real-time RT-PCR for detecting
the expression levels of miR-145, miR-128, and U6. ∗ and ∗∗ Significant difference compared to control (𝑃 < 0.05 and 𝑃 < 0.01); ## significant
difference compared to treatment with insulin alone (𝑃 < 0.01). (b) HepG2 cells and Bel7402 cells were transfected with miR-145, miR-128,
or miRNA scrambled control precursor. After transfection for 24 h, cells were cultured in serum-free medium for 20 h and treated without
or with insulin (200 nM) for 6 h. Protein expression levels of p70S6K1, HIF-1𝛼, PKM2, and GAPDH were determined by immunoblotting.
(c), (d), and (e) Relative protein densities were quantified using ImageJ software. Results are presented as mean ± SD from three independent
experiments. ∗ and ∗∗ Significant difference compared to the value of the scramble control (𝑃 < 0.05 and 𝑃 < 0.01); # and ## significant
difference compared to that treated with insulin alone (𝑃 < 0.05 and 𝑃 < 0.01).
effect of PKM2 on cell proliferation. When compared to
siSCR treatment, inhibition of PKM2 in HepG2 and Bel7402
cells inhibited cell proliferation after the culture for 3-4
days, suggesting that PKM2 affects cell growth in vitro
(Figure 4(e)). Taken together, these data indicate that PKM2
is critical for cell growth.
4. Discussion
Insulin has been shown to induce glucose metabolism and
associated with a variety of cancer development in solid
tumors [1, 27].However, themechanisms of insulin in glucose
metabolism in cancer cells have not been directly examined.
PKM2 is the last rate-limiting glycolytic enzymes of the
glycolytic metabolism, which is preferentially expressed in
embryonic tissue and cancer cells [4, 5]. Studies demonstrate
that during tumor initiation as well as malignant progression
PKM1 disappear and PKM2 reappears which leads to the
switch from regular cell metabolism to aerobic glycoly-
sis [28, 29]. Previous researches have shown that PKM2
may be induced by transcription factors, such as HIF-1𝛼,
while a number of genes associated with cell proliferation,
metabolism, and tumor growth are downstream targets of
PKM2.
Recent evidence has demonstrated the importance of
ROS as secondary messengers in a variety of cellular func-
tions [11–13]. Here, we present evidence that ROS pro-
moted the effects of insulin-induced glycolysis and PKM2
expression in the cultured hepatocellular carcinoma cells.
In general, insulin led to an increase in ROS levels and
addition of catalase blocked the effect of insulin treatment.
This result is consistent with our previous study of insulin-
induced generation of H
2
O
2
in PC-3 cells [14]. More impor-
tantly, ROS levels were positively correlated with insulin-
induced glycolysis. PKM2 has been reported essential for
glycolytic metabolism and insulin stimulates expression of
the PKM2 [5, 28]. We further explored the role of ROS
in the insulin-induced PKM2 expression. Results showed
that insulin significantly induced PKM2 protein and mRNA
expression levels and catalase greatly suppressed the effect
induced by insulin. Expression levels of PKM2 protein and
mRNA were affected, indicating the possible involvement of
other factors in insulin-induced PKM2 expression.
Several miRNAs are reported to be altered in response to
exogenous agents such as insulin and ROS [19–21]. In this
study, we demonstrated that insulin suppressed expression
levels of miR-145 andmiR-128 through ROS production. Our
previous studies showed that miR-145 and miR-128 inhibit
HIF-1𝛼 expression by directly targeting p70S6K1 [25, 26].
Human PKM2 gene sequence revealed a candidate HRE
within the first intron containing the HIF-1 binding site 5󸀠-
ACGTG-3󸀠 followed by a 5󸀠-CACA-3󸀠 sequence, which is
found in many HREs [9, 30]. Correlation between miR-145
and miR-128 expression and insulin-regulated PKM2 expres-
sion further support our conclusion that insulin upregulates
PKM2 expression through miR-145 and miR-128 expression.
However, the mechanism by which insulin and ROS inhibit
miR-145 and miR-128 is currently unknown. One possibility
is that insulin and ROS may affect miR-145 and miR-128
expression through DNA hypermethylation. DNA hyperme-
thylation has been shown to be associated with aberrant
miRNA expression profiles in cancer [31–33]. Further studies
are needed to address how insulin and ROS activate miR-145
and miR-128 in HepG2 and Bel7402 cells.
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Figure 4: Knockdown of PKM2 is sufficient to inhibit insulin-induced glucose consumption, lactate production, and cell proliferation. (a) HepG2 and Bel7402
cells were transfected with siRNA against PKM2 (siPKM2) or scramble control (siSCR) for 48 h.The protein levels of PKM2 were analyzed by immunoblotting. (b)
Relative densities of PKM2/GAPDH from three independent experiments were normalized to those of control and presented as mean ± SD. ∗∗∗ indicate significant
difference when compared to scramble control at 𝑃 < 0.001. (c) and (d) HepG2 and Bel7402 cells were transfected with siRNA against PKM2 (siPKM2) or scramble
control (siSCR) for 24 h, followed by starving in serum-free medium for 24 h.Then, cells were stimulated with insulin (200 nM) for 12 h. Cells were trypsinized and
counted, while the medium was collected. The glucose consumption and lactate production levels were analyzed. Data were mean ± SD from three independent
experiments. ∗∗𝑃 < 0.01 significant difference when compared to cell treated with siSCR; #𝑃 < 0.05 and ##𝑃 < 0.01 significant difference compared to cell treated
with siSCR and insulin. (e) HepG2 and Bel7402 cells were transfected with siRNA against PKM2 (siPKM2) or scramble control (siSCR) for 24 h.The cells were then
trypsinized and resuspended. Cells at 3000 cells per well in a 96-well plate. The cell proliferation was measured at 12 h, 24 h, 48 h, 72 h, and 96 h. Values represent
means ± SD. ∗ and ∗∗ Compared to scramble control (𝑃 < 0.05 and 𝑃 < 0.01).
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In addition, we have shown that knockdown of PKM2
expression decreased insulin-induced aerobic glycolysis and
cancer cell proliferation. This possibly explains the link
between high insulin levels and elevated cancer risk. More-
over, this study may provide some useful information that
PKM2may act as a potential strategy for therapeutic purpose
in liver cancer treatment in the future.
In conclusion, the results from the present study indicate
that ROS promoted the effects of insulin-induced glycolysis
and PKM2 expression in human hepatocellular carcinoma
cells, that insulin upregulates PKM2 expression in ROS
dependent manner through miR-145 and miR-128 suppres-
sion, and that PKM2 is important for insulin-induced aerobic
glycolysis and cell proliferation. Our results contribute to
understanding the role of insulin in cancer metabolism
and also providing new insights into the role of PKM2 in
pathogenesis of liver cancer.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Authors’ Contribution
Qi Li, Xue Liu, and Yu Yin contributed equally to this work.
Acknowledgments
This study was supported in part by the National Key
Basic Research Program of China (2011CB504003), the
National Natural Science Foundation of China (81071642 and
30871296), and NIEHS, National Institutes of Health, Grant
R01ES020868.
References
[1] D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D.
F. Treacher, and R. C. Turner, “Homeostasis model assessment:
insulin resistance and 𝛽-cell function from fasting plasma
glucose and insulin concentrations in man,” Diabetologia, vol.
28, no. 7, pp. 412–419, 1985.
[2] H. Ying, A. C. Kimmelman, C. A. Lyssiotis et al., “Onco-
genic Kras maintains pancreatic tumors through regulation of
anabolic glucose metabolism,” Cell, vol. 149, no. 3, pp. 656–670,
2012.
[3] O. Tavana and C. Zhu, “Too many breaks (brakes): pancreatic
𝛽-cell senescence leads to diabetes,”Cell Cycle, vol. 10, no. 15, pp.
2471–2484, 2011.
[4] T. Nowak and C. Suelter, “Pyruvate kinase: activation by and
catalytic role of themonovalent and divalent cations,”Molecular
and Cellular Biochemistry, vol. 35, no. 2, pp. 65–75, 1981.
[5] H. R. Christofk, M. G. V. Heiden, M. H. Harris et al., “The
M2 splice isoform of pyruvate kinase is important for cancer
metabolism and tumour growth,”Nature, vol. 452, no. 7184, pp.
230–233, 2008.
[6] A. Dae¸browska, J. Pietkiewicz, K. Dae¸browska, E. Czapin´ska,
and R. Danielewicz, “Interaction of M1 and M2 isozymes pyru-
vate kinase fromhuman tissues with phospholipids,”Biochimica
et Biophysica Acta, vol. 1383, no. 1, pp. 123–129, 1998.
[7] H.-S. Shi, D. Li, J. Zhang et al., “Silencing of PKM2 increases the
efficacy of docetaxel in human lung cancer xenografts in mice,”
Cancer Science, vol. 101, no. 6, pp. 1447–1453, 2010.
[8] Q. Sun, X. Chen, J. Ma et al., “Mammalian target of rapamycin
up-regulation of pyruvate kinase isoenzyme type M2 is critical
for aerobic glycolysis and tumor growth,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 108, no. 10, pp. 4129–4134, 2011.
[9] W. Luo, H. Hu, R. Chang et al., “Pyruvate kinase M2 is a PHD3-
stimulated coactivator for hypoxia-inducible factor 1,” Cell, vol.
145, no. 5, pp. 732–744, 2011.
[10] W. Yang, Y. Xia, H. Ji et al., “Nuclear PKM2 regulates 𝛽-catenin
transactivation upon EGFR activation,” Nature, vol. 480, no.
7375, pp. 118–122, 2011.
[11] W. Dro¨ge, “Free radicals in the physiological control of cell
function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002.
[12] R. H. Burdon, “Superoxide and hydrogen peroxide in relation
to mammalian cell proliferation,” Free Radical Biology and
Medicine, vol. 18, no. 4, pp. 775–794, 1995.
[13] T. P. Szatrowski and C. F. Nathan, “Production of large amounts
of hydrogen peroxide by human tumor cells,” Cancer Research,
vol. 51, no. 3, pp. 794–798, 1991.
[14] Q. Zhou, L.-Z. Liu, B. Fu et al., “Reactive oxygen species
regulate insulin-induced VEGF andHIF-1𝛼 expression through
the activation of p70S6K1 in human prostate cancer cells,”
Carcinogenesis, vol. 28, no. 1, pp. 28–37, 2007.
[15] P. Kantharidis, B. Wang, R. M. Carew, and H. Y. Lan, “Diabetes
complications: the microRNA perspective,” Diabetes, vol. 60,
no. 7, pp. 1832–1837, 2011.
[16] P. P. Medina and F. J. Slack, “MicroRNAs and cancer: an
overview,” Cell Cycle, vol. 7, no. 16, pp. 2485–2492, 2008.
[17] S. Srikantan, M. Gorospe, and K. Abdelmohsen, “Senescence-
associated microRNAs linked to tumorigenesis,” Cell Cycle, vol.
10, no. 19, pp. 3211–3212, 2011.
[18] R. Garzon, G. Marcucci, and C. M. Croce, “Targeting microR-
NAs in cancer: rationale, strategies and challenges,” Nature
Reviews Drug Discovery, vol. 9, no. 10, pp. 775–789, 2010.
[19] R. J. A. Frost and E. N. Olson, “Control of glucose homeostasis
and insulin sensitivity by the Let-7 family of microRNAs,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 108, no. 52, pp. 21075–21080, 2011.
[20] S. D. Jordan, M. Kru¨ger, D. M.Willmes et al., “Obesity-induced
overexpression of miRNA-143 inhibits insulin-stimulated AKT
activation and impairs glucose metabolism,” Nature Cell Biol-
ogy, vol. 13, no. 4, pp. 434–448, 2011.
[21] S. Jajoo, D. Mukherjea, T. Kaur et al., “Essential role of
NADPHoxidase-dependent reactive oxygen species generation
in regulating microRNA-21 expression and function in prostate
cancer,”Antioxidants&Redox Signaling, vol. 19, no. 16, pp. 1863–
1876, 2013.
[22] R. Huxley, A. Ansary-Moghaddam, A. B. de Gonza´lez, F. Barzi,
and M. Woodward, “Type-II diabetes and pancreatic cancer: a
meta-analysis of 36 studies,” British Journal of Cancer, vol. 92,
no. 11, pp. 2076–2083, 2005.
[23] H. B. el-Serag, H. Hampel, and F. Javadi, “The association
between diabetes and hepatocellular carcinoma: a systematic
review of epidemiologic evidence,” Clinical Gastroenterology
and Hepatology, vol. 4, no. 3, pp. 369–380, 2006.
[24] V. Rottiers and A. M. Naar, “MicroRNAs in metabolism and
metabolic disorders,” Nature Reviews Molecular Cell Biology,
vol. 13, no. 4, pp. 239–250, 2012.
10 Oxidative Medicine and Cellular Longevity
[25] Q. Xu, L.-Z. Liu, X. Qian et al., “MiR-145 directly targets
p70S6K1 in cancer cells to inhibit tumor growth and angiogen-
esis,” Nucleic Acids Research, vol. 40, no. 2, pp. 761–774, 2012.
[26] Z.-M. Shi, J.Wang, Z. Yan et al., “MiR-128 inhibits tumor growth
and angiogenesis by targeting p70S6K1,” PLoS ONE, vol. 7, no.
3, Article ID e32709, 2012.
[27] A. R. Saltiel and C. R. Kahn, “Insulin signalling and the
regulation of glucose and lipid metabolism,” Nature, vol. 414,
no. 6865, pp. 799–806, 2001.
[28] T. Hitosugi, S. Kang, M. G. V. Heiden et al., “Tyrosine phos-
phorylation inhibits PKM2 to promote the warburg effect and
tumor growth,” Science Signaling, vol. 2, no. 97, Article ID ra73,
2009.
[29] K. Yamada and T. Noguchi, “Regulation of pyruvate kinase M
gene expression,” Biochemical and Biophysical Research Com-
munications, vol. 256, no. 2, pp. 257–262, 1999.
[30] R. Fukuda, H. Zhang, J.-W. Kim, L. Shimoda, C. V. Dang, and
G. Semenza, “HIF-1 regulates cytochrome oxidase subunits to
optimize efficiency of respiration in hypoxic cells,” Cell, vol. 129,
no. 1, pp. 111–122, 2007.
[31] K.-W. Tsai, H.-W. Kao, H.-C. Chen, S.-J. Chen, and W.-C.
Lin, “Epigenetic control of the expression of a primate-specific
microRNA cluster in human cancer cells,” Epigenetics, vol. 4, no.
8, pp. 587–592, 2009.
[32] H. M. O’Hagan, H. P. Mohammad, and S. B. Baylin, “Double
strand breaks can initiate gene silencing and SIRT1-dependent
onset of DNA methylation in an exogenous promoter CpG
island,” PLoS Genetics, vol. 4, no. 8, Article ID e1000155, 2008.
[33] H. O’Hagan, W. Wang, S. Sen et al., “Oxidative damage targets
complexes containing DNA methyltransferases, SIRT1, and
polycombmembers to promoter CpG islands,” Cancer Cell, vol.
20, no. 5, pp. 606–619, 2011.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
